Janus kinase

spinqualitylabelsall models JAK2 kinase domain complex with inhibitor thienopyridine 3tjc Show:Asymmetric Unit Biological Assembly Drag the structure with the mouse to rotate   Export Animated Image   Print3D Function Janus kinase or tyrosine-protein kinase JAK (JAK) are nonreceptor tyrosine kinases which transduces cytokine-mediated signals via the JAK-STAT pathway. The JAK-STAT pathway transmits signals through the cell membrane to DNA promoters thus causing transcription. The name JAK is derived from Just Another Kinase. JAK proteins contain 2 phosphate-transfer domains, one with kinase activity using a phosphotyrosine (PTyr) and the other a pseudokinase domain which negatively regulates the kinase domain. JAK contains seven Janus homology domains named JH1-7. JAK family members are JAK1, JAK2, JAK3 and TYK2. JAK1 and TYK2 are involved in signaling by members of type I and type II cytokine receptors. JAK2 is involved in signaling by members of the interferon receptors (type II cytokines). JAK3 is predominantly active in immune cells. JAK3 is activated by cytokines whose receptors contain the common γ chain subunit (interleukin 2,4,7,9,15,21). TYK2 is a component of type I and type III interferon signaling pathways. See Tyrosine kinase. Relevance Jak3 inhibitors are tested in treatment of autoimmune diseases and transplant rejection. Disease Mutations in Jak2 are associated with chronic myeloproliferative neoplasms, polycythemia vera, essential thrombocytosis and primary myelofibrosis. Mutations in Jak3 are associated with immune deficiency. Structural highlights Jak2 containing phosphotyrosine binds the thienopyridine potent inhibitor in the ATP-binding pocket. Water molecules shown as red spheres. 3D Structures of Janus kinase Janus kinase 3D structures

Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky, Jaime Prilusky, Joel L. Sussman